Impairment of quality of life in patients with antiphospholipid syndrome. (October 2015)

• Record Type: Journal Article
• Authors: Zuily, S; Rat, A-C; Regnault, V; Kaminsky, P; Mismetti, P; Ninet, J; Baillet, N; Magy-Bertrand, N; Pasquali, J-L; Lambert, M; Pasquier, E; Lorcerie, B; Lecompte, T; Guillemin, F; Wahl, D
• Is Part Of: Lupus. Volume 24:Number 11(2015)
• Page Start: 1161
• Page End: 1168
• Publication Date: 2015-10
• Subjects: Antiphospholipid syndrome -- arterial thrombosis -- MOS-SF-36 -- quality of life -- systemic lupus erythematosus; Systemic lupus erythematosus -- Periodicals; 616.772005
• DOI: 10.1177/0961203315580871
• Languages: English
• ISSNs: 0961-2033

Abstract

Objectives: Health-related quality of life (HRQoL) has not been fully explored in antiphospholipid syndrome (APS); therefore, we compared HRQoL between APS patients and the general population and assessed the impact of thromboembolic history. Methods: HRQoL was measured in a multicentre cohort study by the Medical Outcomes Study Short-Form 36 (MOS-SF-36) questionnaire. HRQoL scores were compared to the French general population norms. Factors significantly associated with an impaired HRQoL were identified. Results: A total of 115 patients with aPL and/or systemic lupus erythematosus (SLE) were included (mean age 42.7 ± 14.1 years old, 86 women). In 53 patients APS was diagnosed. Compared to general population norms, patients with APS had an impaired HRQoL. SLE-associated APS patients had the worst HRQoL scores (physical component summary (PCS)=40.8 ± 10.6; mental component summary (MCS)=40.6 ± 16.5) in comparison with SLE or aPL patients without thromboembolic history. In APS patients, history of arterial thrombosis significantly impaired HRQoL (PCS score: 42.2 ± 9.4 vs 49.2 ± 8.5; MCS score: 33.9 ± 13.7 vs 44.6 ± 10.3). Conclusion: Compared to the general population, APS patients experienced a lower HRQoL. In these patients, a history of arterial thrombosis significantly impaired HRQoL. Therefore, measurements of HRQoL should be included in APS patient management to assess the burden of the disease from a patient's perspective and to provide patients with the support they need.